Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus

Annals of Internal Medicine

Volumn 124, Issue 1 II, 1996, Pages 104-109

  Genuth, Saul ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b Mt Sinai Medical Center Cleveland   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN ZINC SUSPENSION; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ADULT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY RISK; DOSE RESPONSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS;

EID: 0030048984     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-124-1_part_2-199601011-00005     Document Type: Article

References (25)

1. Nathan DM. Long-term complications of diabetes mellitus N Engl J Med 1993,328 1676-85
2. Krolewski AS, Czyzyk A, Janeczko D, Kopczynski J. Mortality from cardiovascular diseases among diabetics Diabetologia. 1977,13 345-50.
3. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease the Framingham Study Diabetes Care 1979,2 120-6
4. Kleinman JC, Donahue RP, Harris MI, Finucane FF, Madans JH, Brock DB. Mortality among diabetics in a national sample. Am J Epidemol 1988,128 389-401
5. Moss SE, Klein R, Klein BE. Cause-specific mortality in a population-based study of diabetes Am J Public Health 1991;8:1158-62.
6. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 1993,329 977-86.
7. Lasker RD. The Diabetes control and complications trial Implications for policy and practice [Editorial] N Engl J Med 1993,329.1035-6.
8. Eastman RC, Siebert CW, Harris M, Gorden P. Clinical review 51. Implications of the Diabetes Control and Complications Trial. J Clin Endocrinol Metab 1993,77 1105-7
9. Lebovitz HE. The DCCT and its implications for NIDDM Clinical Diabetes. 1994,12:3-4.
10. Genuth S. Insulin use in NIDDM Diabetes Care 1990,13 1240-64
11. Elliott TG, Viberti G. Relationship between insulin resistance and coronary heart disease in diabetes mellitus and the general population: a critical appraisal Baillieres Clin Endocrinol Metab 1993,7 1079-103
12. Meinert CL, Knatterud GL, Prout TE, Klimt CR. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Diabetes 1970,19 789-830.
13. Knatterud GL, Klimt CR, Levin ME, Jacobson ME, Goldner MG. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment JAMA 1978,240.37-42
14. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes VIII Evaluation of insulin therapy final report Diabetes 1982;31(Suppl 5) 1-78
15. Report of the Committee for the Assessment of Biometric Aspects of Controlled Trials of Hypoglycemic Agents JAMA 1975,231:583-608
16. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance Diabetes. 1979;28. 1039-57.
17. The DCCT Research Group. Diabetes Control and Complications Trial (DCCT), results of feasibility study Diabetes Care 1987,10 1-19
18. Kilo C, Miller JP, Williamson JR. The Achilles heel of the University Group Diabetes Program JAMA. 1980,243 450-7.
19. Kilo C, Miller JP, Williamson JR. The crux of the UGDP Spurious results and biologically inappropriate data analysis Diabetologia 1980,18:179-85.
20. The DCCT Research Group. Implementation of conventional and intensive treatment in the Diabetes Control and Complications Trial Diabetes Care 1995,18 361-75
21. Jarrett RJ. Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease - chicken, egg or neither? Diabetologia. 1984,26:99-102
22. Stern MP, Rosenthal M, Haffner SM. A new concept of impaired glucose tolerance Relation to cardiovascular risk [Editorial] Arteriosclerosis 1985,5 311-4
23. Yamasaki Y, Kawamori R, Matsushima H, Nishizawa H, Kodama M, Kubota M, et al. Asymptomatic hyperglycaemia is associated with increased intimal plus medial thickness of the carotid artery Diabetologia 1995;38 585-91
24. The DCCT Research Group. The effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial Am J Cardiol. 1995,75 894-903
25. UK Prospective Diabetes Study (UKPDS) VIII Study design, progress and performance Diabetologia 1991,34 877-90